Filtered By:
Specialty: Consumer Health News
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of relevance. This is page number 3.
Order by Relevance | Date
Total 55 results found since Jan 2013.
You Can't Take a Vacation From Sleep Apnea
Americans took 2.1 billion trips for business or pleasure in 2014. That's a lot of time away from the comforts of home. For people with sleep apnea, travel creates the dilemma of what to do about their CPAP (continuous positive air pressure) machines: Do I lug it with me or try to struggle through sleep without it? Fortunately, there's good news with more choices in treatments and devices to help apnea sufferers sleep soundly while on the road. You don't want to be tired during your business trip. Sleep apnea is a disorder where breathing stops and starts during sleep (sometimes up to hundreds of times per night) because ...
Source: Healthy Living - The Huffington Post - January 27, 2016 Category: Consumer Health News Source Type: news
6 Simple Health Tips for Buying Chocolate
Shopping for "good" chocolate is kind of like searching for a viable online date. Approach the market without a plan and it's easy to get duped by glossy packaging and false claims. Know what you're looking for, though, and you can find yourself a sweetie with substance -- guaranteed to reduce your stress levels, ignite your sex life, and make your heart sing from the first blissful encounter. In fact, findings from a new long-term study in Heart journal involving 25,000 volunteers suggest that eating up to 3.5 ounces of high-quality chocolate per day can significantly reduce risks of heart disease and stroke. Sort through...
Source: Healthy Living - The Huffington Post - February 14, 2016 Category: Consumer Health News Source Type: news
FDA issues guidelines for reducing salt in processed foods
The Food and Drug administration has proposed guidelines for the food industry to reduce salt in an effort to prevent thousands of deaths every year from heart disease and stroke.
Source: the Mail online | Health - June 2, 2016 Category: Consumer Health News Source Type: news
3 reasons your child shouldn’t go “gluten-free” (unless your doctor says so)
Follow me at @drClaire
There is a puzzling and worrisome new phenomenon that I am seeing as a pediatrician: parents who are putting their children on gluten-free diets.
It’s puzzling because in the vast majority of cases it isn’t necessary — and it’s worrisome because, although parents are doing it because they think it’s healthy, a gluten-free diet can be very unhealthy for children.
Gluten is a protein found in wheat, rye, barley, and some other grains. It’s in bread and other baked goods, cereals, pastas — and in many other foods in small amounts. For people with celiac disease, even those small amounts ca...
Source: New Harvard Health Information - June 7, 2016 Category: Consumer Health News Authors: Claire McCarthy, MD Tags: Children's Health Healthy Eating Parenting Source Type: news
It Won't Be Easy to Reduce the Salt in Our Diets
You might want to take the latest campaign to reduce our daily consumption of sodium with a grain of salt.
On second thought, maybe you shouldn't.
Officials at the Food and Drug Administration (FDA) have announced two-year and 10-year voluntary goals to slowly lower the average daily intake of sodium by Americans.
The reason is simple. Excess sodium consumption can lead to higher blood pressure and other health problems.
Despite the obvious motivation, nutritionists interviewed by Healthline say these goals may not be easy to obtain.
Our propensity for packaged foods and dining out at restaurants has created a salty h...
Source: Healthy Living - The Huffington Post - June 8, 2016 Category: Consumer Health News Source Type: news
In the Raw: To Cook or Not to Cook?
Imagine never again savoring the smell of baking cakes or charbroiled steak.
Could you? Why would you?
Yet some people worldwide are turning away not only from meat and processed food, but also from cooking.
Welcome to the raw food diet.
As the Standard American Diet becomes more fat-laden, sugar-sated, and processed, the prevalence of metabolic disorders, obesity, type 2 diabetes, and cardiovascular disease (CVD) are soaring.
According to the Centers for Disease Control and Prevention (CDC), obesity now affects nearly 35 percent of the population of the United States, over 29 million people have been diagnosed with t...
Source: Healthy Living - The Huffington Post - August 4, 2016 Category: Consumer Health News Source Type: news
Why 5,000 People Are Suing Over Plavix
Legal action is apparently moving forward involving lawsuits filed by thousands of people who say they suffered serious injuries by taking the once-heralded blood-thinning drug Plavix.
The California Supreme Court ruled late last month that eight product liability lawsuits against Plavix manufacturer Bristol-Myers Squibb and Plavix distributor McKesson Corporation can proceed in San Francisco Superior Court.
Those eight cases involved 678 plaintiffs. They may soon be joined by a multitude of other cases, involving about 5,000 plaintiffs, that have been filed around the country.
There is no word yet on whether Bristol-My...
Source: Healthy Living - The Huffington Post - September 13, 2016 Category: Consumer Health News Source Type: news
FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk
(Reuters) - Novo Nordisk said on Friday the U.S. Food and Drug Administration (FDA) approved an expanded use of its diabetes drug to reduce the risk of cardiovascular events such as heart attack and stroke.
Source: Reuters: Health - August 25, 2017 Category: Consumer Health News Tags: healthNews Source Type: news
FDA Approves First Blood Test to Help Diagnose Brain Injuries
(CHICAGO) — The first blood test to help doctors diagnose traumatic brain injuries has won U.S. government approval.
The move means Banyan Biomarkers can commercialize its test, giving the company an early lead in the biotech industry’s race to find a way to diagnose concussions.
The test doesn’t detect concussions and the approval won’t immediately change how patients with suspected concussions or other brain trauma are treated. But Wednesday’s green light by the Food and Drug Administration “is a big deal because then it opens the door and accelerates technology,” said Michael Mc...
Source: TIME: Health - February 15, 2018 Category: Consumer Health News Authors: Lindsey Tanner / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news
How the first postpartum depression drug works
This week the Food and Drug Administration approved the first treatment specifically targeting postpartum depression, a condition that can impact women following childbirth, sometimes even starting during pregnancy. Symptoms can include sadness, loss of energy and feelings of guilt and worthlessness. Dr. David Agus joins "CBS This Morning: Saturday" to discuss how the new drug works and how a new personalized video game can help stroke victims.
Source: Health News: CBSNews.com - March 23, 2019 Category: Consumer Health News Source Type: news
FDA approves expanded label for Regeneron/Sanofi's cholesterol drug
The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc's cholesterol drug Praluent as a treatment to cut the risk of heart attacks, stroke and other major cardiovascular events.
Source: Reuters: Health - April 27, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Novartis ’ Spinal Drug Gets FDA Approval, $2 Million Price Tag
(CNN) — The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants’ muscles to waste away, potentially killing them before age 2.
And then came the price tag: $2.125 million for a one-time treatment.
The gene therapy, called Zolgensma, will be marketed by AveXis, whose parent company is Novartis.
“Today’s approval marks another milestone in the transformational power of gene and cell therapies to treat a wide range of diseases,” Dr. Ned Sharpless, the FDA’s acting commissioner, said in a statement Friday. ̶...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 24, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Novartis Source Type: news
‘We’re Not As Healthy As We Should Be.’ Fitbit CEO James Park Discusses New AFib Detection Partnership With Bristol-Myers Squibb-Pfizer
“We’re not as healthy as we should be.”
That’s what Fitbit CEO and co-founder James Park said at Thursday’s TIME 100 Health Summit, where MSNBC anchor Stephanie Ruhle interviewed him about the company’s future in the health care space, the impact of wearables and just how active Fitbit’s 30 million active users really are.
Ruhle talked with Park about Fitbit’s position as one of the first major wearables company to have gone public, one that led the charge in terms of mass market adoption but has lost ground to competitors offering more advanced wearable devices, as well as ...
Source: TIME: Health - October 17, 2019 Category: Consumer Health News Authors: Patrick Lucas Austin Tags: Uncategorized fitness HealthSummit19 technology Source Type: news
New Drug To Treat Migraines Shows Promise
(CNN) — A new drug to treat migraines has shown promise in a large-scale clinical trial, offering hope to people unable to use current treatment options.
The drug, ubrogepant, showed greater rates of pain and symptom relief from migraine compared to a placebo, with more than 20% of participants given the drug reporting to be pain-free within two hours and more than 34% relieved of the most bothersome symptoms linked to migraine, which include light and noise sensitivity. This is compared to 14% and 27%, respectively, from the placebo.
“Having ubrogepant as a potential new medication for the acute treatment of m...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 19, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Migraines Source Type: news
Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?
Adakveo and Oxbryta could be revolutionary treatments, but each costs about $100,000 per year and must be taken for life.
Source: NYT Health - December 7, 2019 Category: Consumer Health News Authors: Gina Kolata Tags: Drugs (Pharmaceuticals) Health Insurance and Managed Care Sickle Cell Anemia Prices (Fares, Fees and Rates) Stroke Clinical Trials Hemoglobin Food and Drug Administration Novartis AG Global Blood Therapeutics Source Type: news
